ATHIRA PHARMA INC. - COMMON STOCK
0,8024
12-ноября-24 14:38:05
15 мин. задержка
Акции
+0,1559
+24,11%
Сегодняшний диапазон
0,6258 - 0,8264
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Athira Pharma Reports Third Quarter 2024 Financial Results and Pipeline and Business Updates
07 ноя 2024 16:05:02 Источник Nasdaq GlobeNewswire
-
22 окт 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Athira Pharma to Focus on Advancement of ATH-1105 for the Treatment of Neurodegenerative Diseases
17 сен 2024 09:00:00 Источник Nasdaq GlobeNewswire
-
03 сен 2024 16:01:00 Источник Nasdaq GlobeNewswire
-
Athira Pharma Reports Second Quarter 2024 Financial Results and Pipeline and Business Updates
01 авг 2024 16:05:00 Источник Nasdaq GlobeNewswire
-
09 июл 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
12 июн 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
11 июн 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Athira Pharma to Participate in Upcoming June Conferences
29 май 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Athira Pharma Announces Proposed Settlement of Stockholder Derivative Action
17 май 2024 17:00:00 Источник Nasdaq GlobeNewswire
-
Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business Updates
15 май 2024 16:05:00 Источник Nasdaq GlobeNewswire
-
Athira Pharma to Participate in Upcoming May Conferences
02 май 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer
15 апр 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
11 апр 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
03 апр 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
08 мар 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
22 фев 2024 16:05:00 Источник Nasdaq GlobeNewswire
-
08 фев 2024 16:02:00 Источник Nasdaq GlobeNewswire
-
Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update
08 янв 2024 07:00:00 Источник Nasdaq GlobeNewswire
- <<
- <
- 1
- >